BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27628191)

  • 1. Ten-year survival in women with primary stage IV breast cancer.
    Eng LG; Dawood S; Sopik V; Haaland B; Tan PS; Bhoo-Pathy N; Warner E; Iqbal J; Narod SA; Dent R
    Breast Cancer Res Treat; 2016 Nov; 160(1):145-152. PubMed ID: 27628191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
    Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
    Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer.
    Iqbal J; Ginsburg O; Giannakeas V; Rochon PA; Semple JL; Narod SA
    Breast Cancer Res Treat; 2017 Jan; 161(1):103-115. PubMed ID: 27796715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
    Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
    Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
    Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
    Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiac death after adjuvant radiotherapy for breast cancer.
    Giordano SH; Kuo YF; Freeman JL; Buchholz TA; Hortobagyi GN; Goodwin JS
    J Natl Cancer Inst; 2005 Mar; 97(6):419-24. PubMed ID: 15770005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
    Liu YR; Jiang YZ; Yu KD; Shao ZM
    Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of death and relative survival of older women after a breast cancer diagnosis.
    Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
    J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection.
    Schootman M; Fuortes L; Aft R
    Breast Cancer Res Treat; 2006 Sep; 99(1):91-5. PubMed ID: 16555124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis.
    Hinyard L; Wirth LS; Clancy JM; Schwartz T
    Breast; 2017 Apr; 32():13-17. PubMed ID: 28012410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
    Sopik V; Iqbal J; Sun P; Narod SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
    Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
    J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying factors that impact survival among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.
    Rosenberg J; Chia YL; Plevritis S
    Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
    Gnerlich J; Jeffe DB; Deshpande AD; Beers C; Zander C; Margenthaler JA
    Ann Surg Oncol; 2007 Aug; 14(8):2187-94. PubMed ID: 17522944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.